SIRION BIOTECH GmbH 20. Februar 2024

DNA Delivery Systems for Gene Therapies

Dr. Vivienne Raper has written an excellent FutureLab/Biocompare editorial comparing the various DNA delivery systems availble to researchers, including both viral and non-viral vectors.

Modifying a patient’s genes requires the safe and efficient delivery of genetic material into their cells. This is commonly done using a carrier, such as a virus, which needs to successfully transport DNA without the genetic material degrading or triggering a dangerous immunological reaction. The most common carriers remain viral vectors, but non-viral methods are also gaining in popularity.

To read the full article, click here.

SIRION Biotech GmbH bietet kundenspezifische Engineering- und Fertigungsdienstleistungen für virale Vektoren für die Life-Sciences-Ind... [mehr]